Supporting vaccine community with adjuvant and formulation expertise
Supporting adjuvanted vaccine development up to industrial scale
Helping donors and funders carry out vaccine development programs
Interview with Greater Geneva Bern area (GGBa) (January 2024)
Interview with Forbes (November 2023)
